| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 399-411, Copyright © 1998 by American Society for Investigative Pathology
REVIEWS |
M Shoji, WW Hancock, K Abe, C Micko, KA Casper, RM Baine, JN Wilcox, I Danave, DL Dillehay, E Matthews, J Contrino, JH Morrissey, S Gordon, TS Edgington, B Kudryk, DL Kreutzer and FR Rickles
Hematologic Disease Branch, DASTLR/NCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Thrombin-catalyzed, cross-linked fibrin (XLF) formation is a characteristic histopathological finding in many human and experimental tumors and is thought to be of importance in the local host defense response. Although the pathogenesis of tumor-associated fibrin deposition is not entirely clear, several tumor procoagulants have been described as likely primary stimuli for the generation of thrombin (and XLF) in the tumor microenvironment (TME). In a previous study of a variety of human tumors we have shown that tissue factor (TF) is the major procoagulant. However, the relative contribution to fibrin deposition in the TME of tumor cell TF and host cell TF (eg, macrophage- derived) was not established. In addition, recent evidence has implicated TF in the regulation of the synthesis of the pro-angiogenic factor vascular endothelial growth factor (VEGF) by tumor cells. In the current study we used in situ techniques to determine the cellular localization of XLF, TF, VEGF, and an alternative tumor procoagulant, so-called cancer procoagulant (CP), a cysteine protease that activates clotting factor X. In lung cancer we have found XLF localized predominantly to the surface of tumor-associated macrophages, as well as to some endothelial cells and perivascular fibroblasts in the stromal area of the tumors co-distributed with TF at the interface of the tumor and host cells. Cancer pro-coagulant was localized to tumor cells in several cases but not in conjunction with the deposition of XLF. TF and VEGF were co-localized in both lung cancer and breast cancer cells by in situ hybridization and immunohistochemical staining. Furthermore, a strong relationship was found between the synthesis of TF and VEGF levels in human breast cancer cell lines (r2 = 0.84; P < 0.0001). Taken together, these data are consistent with a highly complex interaction between tumor cells, macrophages, and endothelial cells in the TME leading to fibrin formation and tumor angiogenesis.
This article has been cited by other articles:
 |
|
 |
|
  H. H. Versteeg, F. Schaffner, M. Kerver, H. H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B. M. Mueller, and W. Ruf Inhibition of tissue factor signaling suppresses tumor growth Blood, January 1, 2008; 111(1): 190 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Staton, A. S A Chetwood, I. C Cameron, S. S Cross, N. J Brown, and M. W R Reed The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer Gut, October 1, 2007; 56(10): 1426 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mackman, R. E. Tilley, and N. S. Key Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1687 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M.W. Verheul, H. Hammers, K. van Erp, Y. Wei, T. Sanni, B. Salumbides, D. Z. Qian, G. D. Yancopoulos, and R. Pili Vascular Endothelial Growth Factor Trap Blocks Tumor Growth, Metastasis Formation, and Vascular Leakage in an Orthotopic Murine Renal Cell Cancer Model Clin. Cancer Res., July 15, 2007; 13(14): 4201 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koizume, M.-S. Jin, E. Miyagi, F. Hirahara, Y. Nakamura, J.-H. Piao, A. Asai, A. Yoshida, E. Tsuchiya, W. Ruf, et al. Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII Cancer Res., October 1, 2006; 66(19): 9453 - 9460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Adess, R. Eisner, S. Nand, J. Godwin, H. L. Messmore Jr, and W. H. Wehrmacher Thromboembolism in cancer patients: pathogenesis and treatment. Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 254 - 266. [Abstract] [PDF]
|
|
|
|
|
|
A. Sahni, A. A. Khorana, R. B. Baggs, H. Peng, and C. W. Francis FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis Blood, January 1, 2006; 107(1): 126 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Paradis, I Bieche, D Dargere, D Cazals-Hatem, I Laurendeau, V Saada, J Belghiti, A Bezeaud, M Vidaud, P Bedossa, et al. Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease Gut, December 1, 2005; 54(12): 1776 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Criscuoli, M. Nguyen, and B. P. Eliceiri Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability Blood, February 15, 2005; 105(4): 1508 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dorfleutner, E. Hintermann, T. Tarui, Y. Takada, and W. Ruf Cross-talk of Integrin {alpha}3{beta}1 and Tissue Factor in Cell Migration Mol. Biol. Cell, October 1, 2004; 15(10): 4416 - 4425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roselli, T. C. Mineo, S. Basili, F. Martini, S. Mariotti, S. Aloe, G. Del Monte, V. Ambrogi, A. Spila, R. Palmirotta, et al. Soluble CD40 Ligand Plasma Levels in Lung Cancer Clin. Cancer Res., January 15, 2004; 10(2): 610 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T.-P. Poon, C. P.-Y. Lau, J. W.-Y. Ho, W.-C. Yu, S.-T. Fan, and J. Wong Tissue Factor Expression Correlates with Tumor Angiogenesis and Invasiveness in Human Hepatocellular Carcinoma Clin. Cancer Res., November 1, 2003; 9(14): 5339 - 5345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ruf, E. A. Seftor, R. J. Petrovan, R. M. Weiss, L. M. Gruman, N. V. Margaryan, R. E. B. Seftor, Y. Miyagi, and M. J. C. Hendrix Differential Role of Tissue Factor Pathway Inhibitors 1 and 2 in Melanoma Vasculogenic Mimicry Cancer Res., September 1, 2003; 63(17): 5381 - 5389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Versteeg, M. P. Peppelenbosch, and C. A. Spek Tissue factor signal transduction in angiogenesis Carcinogenesis, June 1, 2003; 24(6): 1009 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A.Y. Chung, F. Belgore, F. L. Li-Saw-Hee, D. S.G. Conway, A. D. Blann, and G. Y.H. Lip Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor? Stroke, September 1, 2002; 33(9): 2187 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, E. Gjernes, and H. Prydz Factor VIIa Induces Tissue Factor-dependent Up-regulation of Interleukin-8 in a Human Keratinocyte Line J. Biol. Chem., June 21, 2002; 277(26): 23620 - 23626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Onita, P. G. Ji, J. W. Xuan, H. Sakai, H. Kanetake, P. H. Maxwell, G.-H. Fong, M. Y Gabril, M. Moussa, and J. L. Chin Hypoxia-induced, Perinecrotic Expression of Endothelial Per-ARNT-Sim Domain Protein-1/Hypoxia-inducible Factor-2{alpha} Correlates with Tumor Progression, Vascularization, and Focal Macrophage Infiltration in Bladder Cancer Clin. Cancer Res., February 1, 2002; 8(2): 471 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Samoszuk, M.-Y. Su, A. Najafi, and O. Nalcioglu Selective Thrombosis of Tumor Blood Vessels in Mammary Adenocarcinoma Implants in Rats Am. J. Pathol., July 1, 2001; 159(1): 245 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Smorenburg and C. J. F. Van Noorden The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies Pharmacol. Rev., March 1, 2001; 53(1): 93 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller, S. Mohanam, and J. S. Rao Expression of Tissue Factor Pathway Inhibitor 2 Inversely Correlates during the Progression of Human Gliomas Clin. Cancer Res., March 1, 2001; 7(3): 570 - 576. [Abstract] [Full Text]
|
|
|
|
|
|
H. M. W. Verheul, A. S. Jorna, K. Hoekman, H. J. Broxterman, M. F. B. G. Gebbink, and H. M. Pinedo Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets Blood, December 15, 2000; 96(13): 4216 - 4221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. R. Pendurthi, K. E. Allen, M. Ezban, and L. V. M. Rao Factor VIIa and Thrombin Induce the Expression of Cyr61 and Connective Tissue Growth Factor, Extracellular Matrix Signaling Proteins That Could Act as Possible Downstream Mediators in Factor VIIa{middle dot}Tissue Factor-induced Signal Transduction J. Biol. Chem., May 5, 2000; 275(19): 14632 - 14641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanazawa, M. Ebina, N. Ino-oka, M. Shimizukawa, T. Takahashi, S. Fujimura, T. Imai, and T. Nukiwa Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung Am. J. Pathol., April 1, 2000; 156(4): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Blackwell, Z. Haroon, G. Broadwater, D. Berry, L. Harris, J. D. Iglehart, M. Dewhirst, and C. Greenberg Plasma D-Dimer Levels in Operable Breast Cancer Patients Correlate With Clinical Stage and Axillary Lymph Node Status J. Clin. Oncol., February 1, 2000; 18(3): 600 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. W. Verheul, K. Hoekman, F. Lupu, H. J. Broxterman, P. van der Valk, A. K. Kakkar, and H. M. Pinedo Platelet and Coagulation Activation with Vascular Endothelial Growth Factor Generation in Soft Tissue Sarcomas Clin. Cancer Res., January 1, 2000; 6(1): 166 - 171. [Abstract] [Full Text]
|
|
|
|
|
|
B. B. Sorensen, P.-O. Freskgard, L. S. Nielsen, L. V. M. Rao, M. Ezban, and L. C. Petersen Factor VIIa-induced p44/42 Mitogen-activated Protein Kinase Activation Requires the Proteolytic Activity of Factor VIIa and Is Independent of the Tissue Factor Cytoplasmic Domain J. Biol. Chem., July 23, 1999; 274(30): 21349 - 21354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Abe, M. Shoji, J. Chen, A. Bierhaus, I. Danave, C. Micko, K. Casper, D. L. Dillehay, P. P. Nawroth, and F. R. Rickles Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor PNAS, July 20, 1999; 96(15): 8663 - 8668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hu, Y. Sun, and A. Garen Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model PNAS, July 6, 1999; 96(14): 8161 - 8166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mechtcheriakova, A. Wlachos, H. Holzmuller, B. R. Binder, and E. Hofer Vascular Endothelial Cell Growth Factor-Induced Tissue Factor Expression in Endothelial Cells Is Mediated by EGR-1 Blood, June 1, 1999; 93(11): 3811 - 3823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Even-Ram, M. Maoz, E. Pokroy, R. Reich, B.-Z. Katz, P. Gutwein, P. Altevogt, and R. Bar-Shavit Tumor Cell Invasion Is Promoted by Activation of Protease Activated Receptor-1 in Cooperation with the alpha vbeta 5 Integrin J. Biol. Chem., March 30, 2001; 276(14): 10952 - 10962. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
